CDNA
$78.87
Caredx
($4.50)
(5.40%)
CDNA
Earnings Whisper ®
N/A
1st Quarter March 2021
Consensus: ($0.14)
Revenue: $61.05 Mil
Wednesday
May 26
4:00 PM ET
Share
Watch
Guidance announcement made Wednesday, February 24, 2021
Latest EPS
Wednesday, February 24, 2021
What do you expect when CDNA reports earnings?
Where is CDNA's stock price going from here?
Analysts
Pivots
Resistance
$91.46
$89.76
$86.57
Support
$81.68
$79.98
$76.79
Description
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.